Lane Kiffin and the LSU Tigers continue tinkering the staff in Baton Rouge with a myriad of moving parts occurring behind the scenes. After Kiffin arrived in th ...
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round.
What do you do when you’re passionate about everything? You do everything. Adam Boaks steps up as an educator, club advisor, ...
RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute ...
ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high ...
NEW ORLEANS - Researchers at the LSU LCMC Health Cancer Center have published groundbreaking findings in the medical journal ...